187 related articles for article (PubMed ID: 37906565)
41. Screening strategies for colorectal cancer: a systematic review of the evidence.
McLeod RS;
Can J Gastroenterol; 2001 Oct; 15(10):647-60. PubMed ID: 11694901
[TBL] [Abstract][Full Text] [Related]
42. Colorectal cancer screening: Systematic review of screen-related morbidity and mortality.
Vermeer NC; Snijders HS; Holman FA; Liefers GJ; Bastiaannet E; van de Velde CJ; Peeters KC
Cancer Treat Rev; 2017 Mar; 54():87-98. PubMed ID: 28236723
[TBL] [Abstract][Full Text] [Related]
43. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
45. Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review.
Ali O; Gupta S; Brain K; Lifford KJ; Paranjothy S; Dolwani S
J Med Screen; 2023 Mar; 30(1):14-27. PubMed ID: 36039489
[TBL] [Abstract][Full Text] [Related]
46. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
[TBL] [Abstract][Full Text] [Related]
47. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.
Senore C; Ederle A; Fantin A; Andreoni B; Bisanti L; Grazzini G; Zappa M; Ferrero F; Marutti A; Giuliani O; Armaroli P; Segnan N
J Med Screen; 2011; 18(3):128-34. PubMed ID: 22045821
[TBL] [Abstract][Full Text] [Related]
48. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
[TBL] [Abstract][Full Text] [Related]
49. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
[TBL] [Abstract][Full Text] [Related]
50. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.
Castells A; Bessa X; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas A; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Cosme A; Hernández V; Iglesias B; Castro I; Cid L; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; González-Rubio F; Seoane-Urgorri A; Grau J; Serradesanferm A; Pellisé M; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; de la Vega-Prieto M; Iglesias R; Amador J; Blanco JM; Sastre R; Ferrándiz J; González-Hernández MJ; Andreu M;
J Natl Cancer Inst; 2013 Jun; 105(12):878-86. PubMed ID: 23708054
[TBL] [Abstract][Full Text] [Related]
51. [Necessity and feasibility of screening for colorectal cancer in China].
Zhang SZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
[TBL] [Abstract][Full Text] [Related]
53. The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test.
Berthelsen M; Berstad P; Randel KR; Hoff G; Natvig E; Holme Ø; Botteri E
Cancer Epidemiol; 2022 Oct; 80():102244. PubMed ID: 36057171
[TBL] [Abstract][Full Text] [Related]
54. Colonoscopy-Related Adverse Events in Patients With Abnormal Stool-Based Tests: A Systematic Review of Literature and Meta-analysis of Outcomes.
Chandan S; Facciorusso A; Yarra P; Khan SR; Ramai D; Mohan BP; Kassab LL; Bilal M; Shaukat A
Am J Gastroenterol; 2022 Mar; 117(3):381-393. PubMed ID: 35029161
[TBL] [Abstract][Full Text] [Related]
55. Colorectal cancer screening.
McLoughlin RM; O'Morain CA
World J Gastroenterol; 2006 Nov; 12(42):6747-50. PubMed ID: 17106920
[TBL] [Abstract][Full Text] [Related]
56. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
57. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
58. Colorectal Cancer Screening: Is Colonoscopy the Best Option?
Liang PS; Dominitz JA
Med Clin North Am; 2019 Jan; 103(1):111-123. PubMed ID: 30466668
[TBL] [Abstract][Full Text] [Related]
59. Optimal Strategies for Colorectal Cancer Screening.
Jain S; Maque J; Galoosian A; Osuna-Garcia A; May FP
Curr Treat Options Oncol; 2022 Apr; 23(4):474-493. PubMed ID: 35316477
[TBL] [Abstract][Full Text] [Related]
60. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
